Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127886421 | 12788642 | 1 | I | 20160823 | 20160825 | 20160928 | 20160928 | EXP | GB-MYLANLABS-2016M1037014 | MYLAN | 54.02 | YR | M | Y | 0.00000 | 20160928 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127886421 | 12788642 | 1 | SS | CLOZAPINE. | CLOZAPINE | 1 | Oral | 325 MG, QD | 0 | 325 | MG | TABLET | QD | ||||||
| 127886421 | 12788642 | 2 | PS | RISPERIDONE. | RISPERIDONE | 1 | Oral | 0.5 MG, QD | 76288 | .5 | MG | QD | |||||||
| 127886421 | 12788642 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | 10 MG, QD | D | 0 | 10 | MG | QD | |||||||
| 127886421 | 12788642 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | 40 MG, PM | D | 0 | 40 | MG | QD | |||||||
| 127886421 | 12788642 | 5 | C | COLECALCIFEROL | CHOLECALCIFEROL | 1 | UNK UNK, QD | D | 0 | QD | |||||||||
| 127886421 | 12788642 | 6 | C | DOCUSATE | DOCUSATE | 1 | 200 MG, BID | D | 0 | 200 | MG | BID | |||||||
| 127886421 | 12788642 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 10 MG, QD | D | 0 | 10 | MG | QD | |||||||
| 127886421 | 12788642 | 8 | C | TRIHEXYPHENIDYL | TRIHEXYPHENIDYL | 1 | 5 MG, TID | D | 0 | 5 | MG | TID | |||||||
| 127886421 | 12788642 | 9 | C | TRIMETHOPRIM. | TRIMETHOPRIM | 1 | 200 MG, BID | D | 0 | 200 | MG | BID | |||||||
| 127886421 | 12788642 | 10 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127886421 | 12788642 | 1 | Schizophrenia |
| 127886421 | 12788642 | 2 | Product used for unknown indication |
| 127886421 | 12788642 | 3 | Product used for unknown indication |
| 127886421 | 12788642 | 4 | Product used for unknown indication |
| 127886421 | 12788642 | 5 | Product used for unknown indication |
| 127886421 | 12788642 | 6 | Product used for unknown indication |
| 127886421 | 12788642 | 7 | Product used for unknown indication |
| 127886421 | 12788642 | 8 | Product used for unknown indication |
| 127886421 | 12788642 | 9 | Infection |
| 127886421 | 12788642 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127886421 | 12788642 | OT |
| 127886421 | 12788642 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127886421 | 12788642 | C-reactive protein increased | |
| 127886421 | 12788642 | Haemoglobin increased | |
| 127886421 | 12788642 | Malaise | |
| 127886421 | 12788642 | Neutrophil count increased | |
| 127886421 | 12788642 | Urinary incontinence | |
| 127886421 | 12788642 | Urinary tract infection | |
| 127886421 | 12788642 | Urosepsis | |
| 127886421 | 12788642 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127886421 | 12788642 | 1 | 20160421 | 0 | ||
| 127886421 | 12788642 | 9 | 20160913 | 20160920 | 0 |